Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation
Related Experiment Video
Updated: May 11, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
1Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0006, USA.
Insights
Kelch-like 3 (KLHL3) targets with-no-lysine (K) kinase 4 (WNK4) for degradation, explaining its role in pseudohypoaldosteronism II (PHAII) hypertension. This discovery clarifies KLHL3
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- Mutations in WNK4 and KLHL3 cause pseudohypoaldosteronism II (PHAII), a hereditary hypertension.
- The precise molecular mechanism linking KLHL3 to WNK4 in PHAII pathogenesis remains unclear.
Purpose of the Study:
- To investigate whether KLHL3 regulates WNK4 and its downstream targets.
- To elucidate the role of KLHL3 in the ubiquitination and degradation of WNK4.
Main Methods:
- Experiments were conducted using Xenopus oocytes.
- WNK4 protein abundance, NCC activity, and OSR1 levels were assessed.
- Ubiquitination assays and dominant-negative cullin 3 inhibition were employed.
Main Results:
- KLHL3 inhibited WNK4's positive effect on the Na(+)-Cl(-) cotransporter (NCC).
- KLHL3 decreased WNK4 protein levels without affecting NCC or OSR1 directly.
- KLHL3-induced WNK4 ubiquitination and degradation, which was blocked by dominant-negative cullin 3.
- All tested PHAII mutations in KLHL3 impaired WNK4 regulation.
Conclusions:
- KLHL3 acts as a substrate adaptor for WNK4 within a ubiquitin E3 ligase complex.
- This interaction mediates WNK4 degradation, contributing to PHAII pathogenesis.
- Understanding this pathway offers insights into hypertension mechanisms.
Abstract:
Mutations in with-no-lysine (K) kinase 4 (WNK4) and a ubiquitin E3 ligase complex component kelch-like 3 (KLHL3) both cause pseudohypoaldosteronism II (PHAII), a hereditary form of hypertension. We determined whether WNK4 or its effector is regulated by KLHL3 in Xenopus oocytes. KLHL3 inhibited the positive effect of WNK4 on Na(+)-Cl(-) cotransporter (NCC) by decreasing WNK4 protein abundance without decreasing that of NCC and the downstream kinase OSR1 directly. Ubiquitination and degradation of WNK4 were induced by KLHL3. The effect of KLHL3 on WNK4 degradation was blocked by a dominant negative form of cullin 3. All five PHAII mutations of KLHL3 tested disrupted the regulation on WNK4. We conclude that KLHL3 is a substrate adaptor for WNK4 in a ubiquitin E3 ligase complex.
More Related Videos
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Canonical Wnt Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

